Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy

被引:247
作者
Chaturvedi, Vivek K. [1 ]
Singh, Anshuman [1 ]
Singh, Vinay K. [2 ]
Singh, Mohan P. [1 ]
机构
[1] Univ Allahabad, Ctr Biotechnol, Allahabad 211002, Uttar Pradesh, India
[2] Univ Allahabad, CMP Degree Coll, Allahabad 211002, Uttar Pradesh, India
关键词
Cancer nanotechnology; carbon nanotubes; siRNA; nanobiosensor; anticancer; nanocarriers; PEGYLATED LIPOSOMAL DOXORUBICIN; IN-VIVO; CARBON NANOTUBES; DRUG-DELIVERY; QUANTUM-DOTS; DENDRITIC MACROMOLECULES; MULTIDRUG-RESISTANCE; LOADED NANOPARTICLES; COPOLYMER MICELLES; ANTITUMOR-ACTIVITY;
D O I
10.2174/1389200219666180918111528
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Nanotechnology is gaining significant attention worldwide for cancer treatment. Nano-biotechnology encourages the combination of diagnostics with therapeutics, which is a vital component of a customized way to deal with the malignancy. Nanoparticles are being used as Nanomedicine which participates in diagnosis and treatment of various diseases including cancer. The unique characteristic of Nanomedicine i.e. their high surface to volume ratio enables them to tie, absorb, and convey small biomolecule like DNA, RNA, drugs, proteins, and other molecules to targeted site and thus enhances the efficacy of therapeutic agents. Objective: The objective of the present article is to provide an insight of several aspect of nanotechnology in cancer therapeutics such as various nanomaterials as drug vehicle, drug release strategies and role of nanotechnology in cancer therapy. Methods: We performed an extensive search on bibliographic database for research article on nanotechnology and cancer therapeutics and further compiled the necessary information from various articles into the present article. Results: Cancer nanotechnology confers a unique technology against cancer through early diagnosis, prevention, personalized therapy by utilizing nanoparticles and quantum dots. Nano-biotechnology plays an important role in the discovery of cancer biomarkers. Quantum dots, gold nanoparticles, magnetic nanoparticles, carbon nanotubes, gold nanowires etc. have been developed as a carrier of biomolecules that can detect cancer biomarkers. Nanoparticle assisted cancer detection and monitoring involves biomolecules like proteins, antibody fragments, DNA fragments, and RNA fragments as the base of cancer biomarkers. Conclusion: This review highlights various approaches of cancer nanotechnology in the advancement of cancer therapy.
引用
收藏
页码:416 / 429
页数:14
相关论文
共 145 条
  • [1] Liposome: classification, preparation, and applications
    Akbarzadeh, Abolfazl
    Rezaei-Sadabady, Rogaie
    Davaran, Soodabeh
    Joo, Sang Woo
    Zarghami, Nosratollah
    Hanifehpour, Younes
    Samiei, Mohammad
    Kouhi, Mohammad
    Nejati-Koshki, Kazem
    [J]. NANOSCALE RESEARCH LETTERS, 2013, 8
  • [2] Nanomedicines as Cancer Therapeutics: Current Status
    Akhter, Sohail
    Ahmad, Iqbal
    Ahmad, Mohammad Zaki
    Ramazani, Farshad
    Singh, Anjali
    Rahman, Ziyaur
    Ahmad, Farhan Jalees
    Storm, Gert
    Kok, Robbert J.
    [J]. CURRENT CANCER DRUG TARGETS, 2013, 13 (04) : 362 - 378
  • [3] Liposomal drug delivery systems: From concept to clinical applications
    Allen, Theresa M.
    Cullis, Pieter R.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 36 - 48
  • [4] Alper J., 2005, NCI ALLIANCE NANOTEC, P1
  • [5] Molecular basis for target RNA recognition and cleavage by human RISC
    Ameres, Stefan Ludwig
    Martinez, Javier
    Schroeder, Renee
    [J]. CELL, 2007, 130 (01) : 101 - 112
  • [6] Developing therapeutic microRNAs for cancer
    Bader, A. G.
    Brown, D.
    Stoudemire, J.
    Lammers, P.
    [J]. GENE THERAPY, 2011, 18 (12) : 1121 - 1126
  • [7] ACTION OF STEROIDS AND STREPTOLYSIN S ON PERMEABILITY OF PHOSPHOLIPID STRUCTURES TO CATIONS
    BANGHAM, AD
    STANDISH, MM
    WEISSMANN, G
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) : 253 - +
  • [8] Barenholz Y, 2012, HANDBOOK OF HARNESSING BIOMATERIALS IN NANOMEDICINE: PREPARATION, TOXICITY, AND APPLICATIONS, P335
  • [9] Doxil® - The first FDA-approved nano-drug: Lessons learned
    Barenholz, Yechezkel
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) : 117 - 134
  • [10] Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era (vol 7, pg 1409, 2014)
    Berger, J. L.
    Smith, A.
    Zorn, K. K.
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 593 - 593